Colan Totte.Co.,Ltd.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Colan Totte.Co.,Ltd. owes ¥0.20 for every ¥1 it owns. Net profit rose 30% in the year to Sep 2025, and grew 30% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Sep 2025.
P/E ratio
9.3Investors pay ¥9.3 for every ¥1 of Colan Totte.Co.,Ltd.'s yearly profit, lower than 88% of Healthcare companies in Japan.
P/B ratio
2.21The share price is 2.21 times Colan Totte.Co.,Ltd.'s book value per share, higher than 69% of Healthcare companies in Japan.
Market cap
¥13.1 BThe total market value of all of Colan Totte.Co.,Ltd.'s shares at today's price (share price × number of shares), smaller than 56% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥6.0 BWhat Colan Totte.Co.,Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥654.89Net worth divided by the number of shares. The share price of ¥1,444 is 2.2 times this, which is the P/B above.
Return on equity (ROE)
26.0%Colan Totte.Co.,Ltd. earned 26.0% on its shareholders' money over the last year, higher than 95% of Healthcare companies in Japan.
Owes vs Owns
0.20×Colan Totte.Co.,Ltd. owes ¥0.20 for every ¥1 it owns (low), lower than 77% of Healthcare companies in Japan.
Dividend yield
3.03%Colan Totte.Co.,Ltd. pays 3.03% of its share price as dividends a year, higher than 58% of dividend-paying Healthcare companies in Japan.
Revenue growth
+16%Revenue rose 16% in the year to Sep 2025, and grew 14% a year on average over 3 years.
Profit growth
+30%Net profit rose 30% in the year to Sep 2025, and grew 30% a year on average over 3 years.
Profit margin
19.2%Colan Totte.Co.,Ltd. keeps ¥19 of every ¥100 of revenue as net profit.
Cash quality
0.8×Cash from Colan Totte.Co.,Ltd.'s business was 0.8× its reported profit in the year to Sep 2025 — less cash came in than the profit reported.
Cash vs debt
Net cashColan Totte.Co.,Ltd. held ¥2.2 B more cash than debt (net cash) at Sep 2025.
Questions
What is Colan Totte.Co.,Ltd.'s P/E ratio?
Investors pay ¥9.3 for every ¥1 of Colan Totte.Co.,Ltd.'s yearly profit, lower than 88% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Colan Totte.Co.,Ltd.: ¥13.1 B ÷ ¥6.0 B (30 Jun 2026) = 2.2.
What is Colan Totte.Co.,Ltd.'s return on equity?
Colan Totte.Co.,Ltd. earned 26.0% on its shareholders' money over the last year, higher than 95% of Healthcare companies in Japan.
How much does Colan Totte.Co.,Ltd. owe compared with what it owns?
Colan Totte.Co.,Ltd. owes ¥0.20 for every ¥1 it owns (low), lower than 77% of Healthcare companies in Japan.
Does Colan Totte.Co.,Ltd. pay a dividend?
Yes. Colan Totte.Co.,Ltd. pays 3.03% of its share price as dividends a year, higher than 58% of dividend-paying Healthcare companies in Japan.
Is Colan Totte.Co.,Ltd.'s revenue growing?
Revenue rose 16% in the year to Sep 2025, and grew 14% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.